Hanne Jensen
Profile
Hanne Damgaard Jensen currently works at ROS-Therapeutics ApS, as Chief Executive Officer from 2018, Aimvion A, as Chairman from 2020, and Curasight A, as Chief Operating & Development Officer from 2022.
Ms. Jensen also formerly worked at Azanta A, as Chief Executive Officer from 2009 to 2017, Johnson & Johnson, as Principal, Novo Nordisk A, as Project Manager from 1995 to 1999, Genmab A, as Senior Vice President-Drug Development, and Roche Innovation Center Copenhagen A, as Senior Vice President-Product Development from 2007 to 2008.
Ms. Jensen received her Masters Business Admin degree from Copenhagen Business School, graduate degree from the University of Copenhagen, and Masters Business Admin degree from Scandinavian International Management Institute.
Hanne Jensen active positions
| Companies | Position | Start |
|---|---|---|
| CURASIGHT A/S | Chief Operating Officer | 01/01/2022 |
ROS-Therapeutics ApS | Chief Executive Officer | 01/01/2018 |
Aimvion A/S
Aimvion A/S Provides services for autoimmune diseases and biotechnology | Chairman | 01/01/2020 |
Former positions of Hanne Jensen
| Companies | Position | End |
|---|---|---|
Azanta A/S
Azanta A/S Pharmaceuticals: MajorHealth Technology Provides pharmaceutical drugs within oncology, women's healthcare, and addiction medicine | Chief Executive Officer | 01/01/2017 |
Roche Innovation Center Copenhagen A/S
Roche Innovation Center Copenhagen A/S Pharmaceuticals: MajorHealth Technology Discovers and develops drugs for the treatment of oncology, metabolic diseases, and infectious diseases | Corporate Officer/Principal | 01/01/2008 |
| GENMAB A/S | Corporate Officer/Principal | - |
| NOVO NORDISK A/S | Corporate Officer/Principal | 01/01/1999 |
| JOHNSON & JOHNSON | Corporate Officer/Principal | - |
Training of Hanne Jensen
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 11 |
|---|---|
Johnson & Johnson
Johnson & Johnson Operates as an investment holding company with interests in health care products | |
Novo Nordisk A/S
Novo Nordisk A/S Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical products for diabetes care | Health Technology |
Genmab A/S
Genmab A/S Pharmaceuticals: MajorHealth Technology Develops differentiated antibody therapeutics for treatment of cancer | Health Technology |
Copenhagen Business School
Copenhagen Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Roche Innovation Center Copenhagen A/S
Roche Innovation Center Copenhagen A/S Pharmaceuticals: MajorHealth Technology Discovers and develops drugs for the treatment of oncology, metabolic diseases, and infectious diseases | Health Technology |
University of Copenhagen
University of Copenhagen Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Scandinavian International Management Institute
Scandinavian International Management Institute Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Azanta A/S
Azanta A/S Pharmaceuticals: MajorHealth Technology Provides pharmaceutical drugs within oncology, women's healthcare, and addiction medicine | Health Technology |
Curasight A/S
Curasight A/S Provides PET imaging research techniques for prostate cancer | |
Aimvion A/S
Aimvion A/S Provides services for autoimmune diseases and biotechnology | |
ROS-Therapeutics ApS |
- Stock Market
- Insiders
- Hanne Jensen
















